Nereida J Ragazzoni, OD in Trussville, AL - Medicare Optometry Provider

Nereida J Ragazzoni, OD is a medicare enrolled "Optometrist" provider in Trussville, Alabama. She graduated from medical school in 2019 and has 5 years of diverse experience with area of expertise as Optometry. She is a member of the group practice Myeyedr Optometry Of Alabama Llc and her current practice location is 129 N Chalkville Rd, Trussville, Alabama. You can reach out to her office (for appointments etc.) via phone at (205) 445-2020.

Nereida J Ragazzoni is licensed to practice in Alabama (license number S-E29-TA-B63) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1427601285.

Contact Information

	Nereida J Ragazzoni, OD
	129 N Chalkville Rd, Trussville, AL 35173-1376
	(205) 445-2020
	Not Available

Healthcare Provider's Profile

Full Name	Nereida J Ragazzoni
Gender	Female
Speciality	Optometry
Experience	5 Years
Location	129 N Chalkville Rd, Trussville, Alabama
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Nereida J Ragazzoni graduated from medical school in 2019

NPI Data:

NPI Number: 1427601285
Provider Enumeration Date: 07/22/2019
Last Update Date: 03/10/2022

Medicare PECOS Information:

PECOS PAC ID: 3274951421
Enrollment ID: I20200921000645

Medical Identifiers

Medical identifiers for Nereida J Ragazzoni such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1427601285	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
152W00000X	Optometrist	S-E29-TA-B63 (Alabama)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Myeyedr Optometry Of Alabama Llc	0840559878	33

News Archive

Sagent launches chemotherapy agent topotecan hydrochloride for injection

Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced U.S. FDA approval and launch of its topotecan hydrochloride for injection, a chemotherapy agent, in conjunction with the innovator's patent expiry. Sagent's topotecan is available in 4 mg single-dose latex-free vials.

Risk for schizophrenia and bipolar disorder has distinct effects on the brain

Brain abnormalities in people at familial risk of schizophrenia and bipolar disorder emerge in unique patterns, despite the symptom and genetic overlap of the disorders, according to a study in Biological Psychiatry, published by Elsevier.

Research suggests that a common mechanism may underlie a variety of protein folding diseases

Misfolded and damaged proteins are common to all human neurodegenerative diseases. Clumps of these aggregated proteins destroy neurons within the brain and cause disease.

Mouth may be primary route of SARS-CoV-2 infection and transmission

A new study published on the preprint server medRxiv in October 2020 shows that the virus also multiplies robustly in the oral cavity, indicating that saliva plays a role in viral transmission.

Capsules: Fiscal deal kills future funding for health law's co-ops; Consumers may draw wrong conclusions from medical prices

Now on Kaiser Health News' blog, Phil Galewitz reports on a 'fiscal cliff' development that will impact health insurance co-ops: "The fiscal cliff deal, approved by Congress on New Year's Day, eliminates most of the more than $1.4 billion in remaining funding from the federal health law for new nonprofit, customer-owned health plans designed to compete against the major for-profit insurers."

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Nereida J Ragazzoni allows following entities to bill medicare on her behalf.

Provider Name	Myeyedr Optometry Of Alabama Llc
Provider Type	Part B Supplier - Clinic/group Practice
Provider Identifiers	NPI Number: 1770093551 PECOS PAC ID: 0840559878 Enrollment ID: O20180118002553

News Archive

Sagent launches chemotherapy agent topotecan hydrochloride for injection

Risk for schizophrenia and bipolar disorder has distinct effects on the brain

Research suggests that a common mechanism may underlie a variety of protein folding diseases

Misfolded and damaged proteins are common to all human neurodegenerative diseases. Clumps of these aggregated proteins destroy neurons within the brain and cause disease.

Mouth may be primary route of SARS-CoV-2 infection and transmission

A new study published on the preprint server medRxiv in October 2020 shows that the virus also multiplies robustly in the oral cavity, indicating that saliva plays a role in viral transmission.

Capsules: Fiscal deal kills future funding for health law's co-ops; Consumers may draw wrong conclusions from medical prices

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Nereida J Ragazzoni is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Nereida J Ragazzoni, OD 1950 Old Gallows Rd Ste 520, Vienna, VA 22182-3970 Ph: () -	Nereida J Ragazzoni, OD 129 N Chalkville Rd, Trussville, AL 35173-1376 Ph: (205) 445-2020

News Archive

Sagent launches chemotherapy agent topotecan hydrochloride for injection

Risk for schizophrenia and bipolar disorder has distinct effects on the brain

Research suggests that a common mechanism may underlie a variety of protein folding diseases

Misfolded and damaged proteins are common to all human neurodegenerative diseases. Clumps of these aggregated proteins destroy neurons within the brain and cause disease.

Mouth may be primary route of SARS-CoV-2 infection and transmission

A new study published on the preprint server medRxiv in October 2020 shows that the virus also multiplies robustly in the oral cavity, indicating that saliva plays a role in viral transmission.

Capsules: Fiscal deal kills future funding for health law's co-ops; Consumers may draw wrong conclusions from medical prices

Optometrist in Trussville, AL

Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 133 N Chalkville Rd, Trussville, AL 35173 Phone: 205-655-4838
Emily Ann Chaney Compton, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 129 N Chalkville Rd, Trussville, AL 35173 Phone: 205-445-2020 Fax: 205-655-3194
Dr. Kristen A Weslock, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 129 N Chalkville Rd, Trussville, AL 35173 Phone: 205-445-2020 Fax: 205-655-3194
Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 322 Main St, Trussville, AL 35173 Phone: 205-445-2020 Fax: 205-655-3194
Dr. Jason Lane Stephenson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 129 N Chalkville Rd, Trussville, AL 35173 Phone: 205-445-2020 Fax: 205-655-3194
Dr. Christine M Mikolaj, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 129 N Chalkville Rd, Trussville, AL 35173 Phone: 205-661-2080 Fax: 205-661-2085
Lowe Family Eye Care, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 133 N Chalkville Rd, Trussville, AL 35173 Phone: 205-655-4838

Nereida J Ragazzoni, OD - Medicare Optometrist in Trussville, AL

Contact Information

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Sagent launches chemotherapy agent topotecan hydrochloride for injection

Risk for schizophrenia and bipolar disorder has distinct effects on the brain

Research suggests that a common mechanism may underlie a variety of protein folding diseases

Mouth may be primary route of SARS-CoV-2 infection and transmission

Capsules: Fiscal deal kills future funding for health law's co-ops; Consumers may draw wrong conclusions from medical prices

Medicare Reassignments

Sagent launches chemotherapy agent topotecan hydrochloride for injection

Risk for schizophrenia and bipolar disorder has distinct effects on the brain

Research suggests that a common mechanism may underlie a variety of protein folding diseases

Mouth may be primary route of SARS-CoV-2 infection and transmission

Capsules: Fiscal deal kills future funding for health law's co-ops; Consumers may draw wrong conclusions from medical prices

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Sagent launches chemotherapy agent topotecan hydrochloride for injection

Risk for schizophrenia and bipolar disorder has distinct effects on the brain

Research suggests that a common mechanism may underlie a variety of protein folding diseases

Mouth may be primary route of SARS-CoV-2 infection and transmission

Capsules: Fiscal deal kills future funding for health law's co-ops; Consumers may draw wrong conclusions from medical prices

Optometrist in Trussville, AL